Posted in | News | Nanomedicine

Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine

Arrowhead Research Corporation (NASDAQ: ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference at 5:45 p.m. EDT on Tuesday, September 14, 2010, at the Palace Hotel in New York, NY.

Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.

Source: http://www.arrowheadresearch.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Arrowhead Pharmaceutical. (2019, February 13). Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine. AZoNano. Retrieved on December 06, 2022 from https://www.azonano.com/news.aspx?newsID=19415.

  • MLA

    Arrowhead Pharmaceutical. "Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine". AZoNano. 06 December 2022. <https://www.azonano.com/news.aspx?newsID=19415>.

  • Chicago

    Arrowhead Pharmaceutical. "Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine". AZoNano. https://www.azonano.com/news.aspx?newsID=19415. (accessed December 06, 2022).

  • Harvard

    Arrowhead Pharmaceutical. 2019. Arrowhead Research CEO to Discuss Company’s Focus on Nanomedicine. AZoNano, viewed 06 December 2022, https://www.azonano.com/news.aspx?newsID=19415.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit